title: 18F-FDG PET in candidates for radiation therapy: is it important and how do we validate its impact?
authors.affiliation: Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.
authors.forename: Rodney J
authors.initials: RJ
authors.lastname: Hicks
authors.forename: Michael P
authors.initials: MP
authors.lastname: Mac Manus
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy*; D010346:Patient Care Management / Q000379:methods; D018579:Patient Selection; D011237:Predictive Value of Tests; D019275:Radiopharmaceuticals; D011878:Radiotherapy / Q000379:methods; D014055:Tomography, Emission-Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18